STING1 and chronic hepatitis C virus infection: Previous studies focusing on the response to interferon (IFN) treatment in chronic hepatitis C (CHC) revealed the existence of a subset of patients with high endogenous levels of interferon‐stimulated genes (ISGs; Sarasin‐Filipowicz et al, 2008).